Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medications (Q92223335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

title

Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

1 reference

David M Kern

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

M Soledad Cepeda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

Simon Lovestone

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

Guy R Seabrook

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

publication date

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

Alzheimer's & dementia (New York, N. Y.)

28 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

page(s)

862-870

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

Cholinesterase inhibitors for Alzheimer's disease

28 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

A population-based study of dosing and persistence with anti-dementia medications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Alzheimer's disease drug development pipeline: 2018.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Oophorectomy, estrogen, and dementia: a 2014 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Real-World Evidence - What Is It and What Can It Tell Us?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

A comparison of the empirical performance of methods for a risk identification system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Antidepressant activity of linezolid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Oral Anticoagulants and Risk of Dementia: A Systematic Review and Meta-analysis of Observational Studies and Randomized Controlled Trials

7 January 2021

2 references

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

7 January 2021

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909196

Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?

23 February 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk-An analysis of Finnish health register and German health insurance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Antiepileptic drugs in neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Antiepileptic drugs and neuroprotection: current status and future roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Neuroprotective strategies in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Neuroprotective therapeutics for Alzheimer's disease: progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Bacterial infection and Alzheimer's disease: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Granulocyte colony stimulating factor (GCSF) improves memory and neurobehavior in an amyloid-β induced experimental model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Pilot study of granulocyte-colony stimulating factor for treatment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

New advances in NMDA receptor pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Statins, cognition, and dementia—systematic review and methodological commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRCI.2019.07.012

Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug Discovery

7 January 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909196

Atrial fibrillation, antithrombotic treatment, and cognitive aging: A population-based study

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909196

Treatment for Dementia: Learning from Breakthroughs for Other Conditions

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909196

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909196

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6909196

10.1016/J.TRCI.2019.07.012

23 February 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31872043 AND SRC:MED&resulttype=core&format=json

28 April 2020

PubMed publication ID

31872043

1 reference